179 related articles for article (PubMed ID: 29670757)
1. Gastric inhibitory polypeptide receptor antagonist, SKL-14959, suppressed body weight gain on diet-induced obesity mice.
Nakamura T; Tanimoto H; Mizuno Y; Okamoto M; Takeuchi M; Tsubamoto Y; Noda H
Obes Sci Pract; 2018 Apr; 4(2):194-203. PubMed ID: 29670757
[TBL] [Abstract][Full Text] [Related]
2. GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice.
Nakamura T; Tanimoto H; Okamoto M; Takeuchi M; Tsubamoto Y; Noda H
Diabetes Metab Syndr Obes; 2021; 14():1095-1105. PubMed ID: 33727843
[TBL] [Abstract][Full Text] [Related]
3. Biological and functional characteristics of a novel low-molecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo.
Nakamura T; Tanimoto H; Mizuno Y; Tsubamoto Y; Noda H
Diabetes Obes Metab; 2012 Jun; 14(6):511-7. PubMed ID: 22192426
[TBL] [Abstract][Full Text] [Related]
4. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
Gault VA; McClean PL; Cassidy RS; Irwin N; Flatt PR
Diabetologia; 2007 Aug; 50(8):1752-62. PubMed ID: 17558485
[TBL] [Abstract][Full Text] [Related]
5. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
[TBL] [Abstract][Full Text] [Related]
6. Antiobesity effects of kimchi added with Jeju citrus concentrate on high-fat diet-induced obese mice.
Yun YR; Kim HC; Seo HY
Nutr Res; 2021 Feb; 86():50-59. PubMed ID: 33482598
[TBL] [Abstract][Full Text] [Related]
7. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
[TBL] [Abstract][Full Text] [Related]
8. (Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy.
McClean PL; Irwin N; Hunter K; Gault VA; Flatt PR
Br J Pharmacol; 2008 Nov; 155(5):690-701. PubMed ID: 18695644
[TBL] [Abstract][Full Text] [Related]
9. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
Thondam SK; Cuthbertson DJ; Wilding JPH
Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
[TBL] [Abstract][Full Text] [Related]
10. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
Irwin N; McClean PL; O'Harte FP; Gault VA; Harriott P; Flatt PR
Diabetologia; 2007 Jul; 50(7):1532-40. PubMed ID: 17486314
[TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice.
Boer GA; Hunt JE; Gabe MBN; Windeløv JA; Sparre-Ulrich AH; Hartmann B; Holst JJ; Rosenkilde MM
Br J Pharmacol; 2022 Sep; 179(18):4486-4499. PubMed ID: 35710141
[TBL] [Abstract][Full Text] [Related]
12. Effects of calcium salts of palm oil inclusion and ad libitum feeding regimen on growth performance, carcass characteristics, and plasma glucose-dependent insulinotropic polypeptide concentration of feedlot steers.
Pittaluga AM; Ortiz-Fraguada MY; Parker AJ; Relling AE
J Anim Sci; 2022 Sep; 100(9):. PubMed ID: 35830482
[TBL] [Abstract][Full Text] [Related]
13. Triterpene alcohols and sterols from rice bran lower postprandial glucose-dependent insulinotropic polypeptide release and prevent diet-induced obesity in mice.
Fukuoka D; Okahara F; Hashizume K; Yanagawa K; Osaki N; Shimotoyodome A
J Appl Physiol (1985); 2014 Dec; 117(11):1337-48. PubMed ID: 25257874
[TBL] [Abstract][Full Text] [Related]
14. Medium-chain triglyceride diet stimulates less GIP secretion and suppresses body weight and fat mass gain compared with long-chain triglyceride diet.
Murata Y; Harada N; Yamane S; Iwasaki K; Ikeguchi E; Kanemaru Y; Harada T; Sankoda A; Shimazu-Kuwahara S; Joo E; Poudyal H; Inagaki N
Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E53-E64. PubMed ID: 30990747
[TBL] [Abstract][Full Text] [Related]
15. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.
Darkhal P; Gao M; Ma Y; Liu D
Int J Obes (Lond); 2015 Aug; 39(8):1292-9. PubMed ID: 25869601
[TBL] [Abstract][Full Text] [Related]
16. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes.
Gault VA; Irwin N; Green BD; McCluskey JT; Greer B; Bailey CJ; Harriott P; O'harte FP; Flatt PR
Diabetes; 2005 Aug; 54(8):2436-46. PubMed ID: 16046312
[TBL] [Abstract][Full Text] [Related]
17. Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice.
McShane LM; Irwin N; O'Flynn D; Franklin ZJ; Hewage CM; O'Harte FP
J Endocrinol; 2016 Jun; 229(3):319-30. PubMed ID: 27098830
[TBL] [Abstract][Full Text] [Related]
18. Absence of GIP secretion alleviates age-related obesity and insulin resistance.
Kanemaru Y; Harada N; Shimazu-Kuwahara S; Yamane S; Ikeguchi E; Murata Y; Kiyobayashi S; Hatoko T; Inagaki N
J Endocrinol; 2020 Apr; 245(1):13-20. PubMed ID: 31977316
[TBL] [Abstract][Full Text] [Related]
19. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
[TBL] [Abstract][Full Text] [Related]
20. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
